Strengthens Farm to Formula® Positioning, Advancing Innovation & Expansion into the 'Better for You' Consumer Products Right Product at the Right Time - Launch Aligns with Rapid Expansion in Global Sports Nutrition Market BELVIDERE, NJ, May 20, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that it has officially ...

HBC recorded total operating revenues of NOK 60.9 million in the first quarter of 2025, compared to NOK 52.4 million in the same period last year. Net operating revenues were NOK 60.7 million, reflecting a 15% increase from Q1 2024 (NOK 52.1 million), driven by continued growth in higher-margin human and pet health segments, despite early-quarter production constraints and ongoing pressure in the commodity oil market. Cost of goods sold (CoGS) amounted to NOK 37.5 million, up from NOK 27.3 million in Q1 202 ...

BioHarvest Sciences (BHST) Q1 2025 Earnings Call May 15, 2025 04:30 PM ET Company Participants Ilan Sobel - CEOBar Dichter - CFONicholas Sherwood - Equity Research AssociateHunter Diamond - Owner Conference Call Participants Matt Hewitt - Senior Research AnalystAmit Dayal - Managing Director & Senior Technology AnalystSusan Anderson - Managing Director & Senior Analyst Operator Greetings, and welcome to the BioHarvest Sciences First Quarter twenty twenty five Corporate Update Conference Call. At this time, ...

OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024. Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the firs ...

The Beachbody Company (BODI) Q1 2025 Earnings Call May 14, 2025 05:00 PM ET Company Participants Bruce Williams - Managing DirectorMark Goldston - Executive ChairmanCarl Daikeler - Co-Founder, Chairman and CEOBrad Ramberg - Interim Chief Financial OfficerAlec Legg - Vice President , Equity Research Conference Call Participants George Kelly - Managing Director, Senior Research AnalystChristopher Sakai - Analyst Operator Good afternoon. Thank you for attending today's Beachbody Company Inc. First Quarter twen ...

The Beachbody Company (BODI) Q1 2025 Earnings Call May 14, 2025 05:00 PM ET Speaker0 Good afternoon. Thank you for attending today's Beachbody Company Inc. First Quarter twenty twenty five Earnings Conference Call. My name is Victoria, and I will be your moderator for today's call. All lines will be muted during the presentation portion of the call with the opportunity for questions I would now like to pass the conference over to your host, Bruce Williams, Managing Director of ICR. You may proceed, Bruce. S ...

文章核心观点 公司2025财年第三季度和前九个月净销售额同比增长，但仍因工厂产能未充分利用、β-丙氨酸特许权和许可收入降低、运营费用增加等因素持续亏损 ，预计2025财年整体仍将净亏损 不过公司对未来销售增长和盈利恢复持乐观态度 [1][3][5] 财务业绩 第三季度 - 净销售额2880万美元，同比增加360万美元，增幅14% [1][2] - 净亏损220万美元，合摊薄后每股亏损0.37美元，上年同期净亏损160万美元，合摊薄后每股亏损0.27美元 [1] - 自有品牌合同制造销售额增长20%，达2710万美元 [2] - CarnoSyn β-丙氨酸特许权、许可和原材料销售收入下降36%，至170万美元 [3] 前九个月 - 净销售额9600万美元，同比增加1170万美元，增幅14% [4] - 净亏损640万美元，合摊薄后每股亏损1.07美元，上年同期净亏损530万美元，合摊薄后每股亏损0.91美元 [3] - 自有品牌合同制造销售额增长16%，达9000万美元 [4] - CarnoSyn β-丙氨酸特许权、许可和原材料销售收入下降9%，至600万美元 [4] 运营情况 - 持续运营亏损，主要因工厂产能未充分利用、β-丙氨酸特许权和许可收入降低、运营费用增加，制造费用受劳动力、外汇汇率等成本上升影响 [5] - 2025财年第四季度销售预计同比增加，但预计2025财年整体仍将净亏损 [5] 财务状况 - 截至2025年3月31日，现金1060万美元，营运资金3520万美元，分别低于2024年6月30日的1200万美元和3810万美元 [6] - 截至2025年3月31日，信贷额度借款能力850万美元，未偿还借款200万美元 [6] 管理层观点 - 公司对营收持续增长感到鼓舞，认为销售团队在开拓新客户关系和现有客户有机销售增长方面取得成果，相信这些努力将使公司在未来一年恢复盈利 [7] - 密切关注供应链、客户订单流和货币估值带来的挑战 [7] - 对新TriBsyn™产品的市场兴趣感到鼓舞，预计含该创新成分的新产品将在近期于零售渠道商业推出 [7]

业绩总结 - 2025财年第四季度收入为2.453亿美元，同比增长10%[72] - 2025财年第四季度净收入为8480万美元，同比增长12%[74] - 2025财年第四季度稀释每股收益（EPS）为0.78美元，同比增长18%[72] - 2025财年总收入为9.744亿美元，同比增长6%[74] - 2025财年总净收入为8430万美元，同比增长12%[74] - 2025财年稀释每股收益（EPS）为4.03美元，同比增长12%[74] - 2025财年经营收入为1.192亿美元，同比增长15%[74] - 2025财年毛利润为8430万美元，同比增长12%[74] - 2023财年公司实现收入9.744亿美元，同比增长6%[75] - 2023财年公司实现毛利润2.255亿美元，同比增长16%[75] - 2023财年每股收益（EPS）为4.03美元，同比增长12%[75] - 2023财年经营现金流为1.111亿美元[75] - 2023财年调整后息税折旧摊销前利润（Adjusted EBITDA）为1.675亿美元，同比增长17%[75] 用户数据与市场展望 - 水处理业务2023财年销售额为3.465亿美元，预计2025财年将达到4.465亿美元，年复合增长率为23%[102] - 工业业务2023财年销售额为4.708亿美元，预计2025财年将达到3.825亿美元，年复合增长率为7%[103] - 健康与营养业务2023财年销售额为1.594亿美元，预计2025财年将达到1.455亿美元，年复合增长率为7%[121] - 2023财年健康与营养业务的毛利润为2.98亿美元，预计2025财年将达到3.13亿美元，年复合增长率为9%[123] 现金流与经营情况 - 2025财年经营现金流为1.111亿美元，同比减少30%[69] - 2023财年公司运营收入为4.24亿美元，包含300万美元的资产出售收益[110] - 过去五年每股收益（EPS）年复合增长率为25%[24]

The Beachbody Company Ticker: BODi May 2024 FORWARD-LOOKING STATEMENTS Ticker: BODi § This presentation of The Beachbody Company, Inc. (the "Company") contains "forward-looking" statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which are statements other than historical fact or in the future tense. These statements include but are not limited to statements regarding the Company's future performance and market opportunity, including expected financial ...

清晨七点,城市尚未完全苏醒,28岁的林悦已在梳妆台前开启新的一天。她拧开metoday"日间光感小白 瓶",一粒晶莹的胶囊滑入掌心,植物胶囊在晨光中泛着温润光泽。这抹来自新西兰的纯净能量,即将伴随 她奔赴又一个充满挑战的职场战场。这样的场景,正在全球14个国家和地区的都市女性生活中上演—— metoday以天然营养美学为笔,正在书写属于现代女性的焕活故事。 对于像林悦这样的职场女性,"日间光感小白瓶"是会议室里的隐形铠甲——生物素与植愈力成分协同作 用,让连续加班后的肌肤依然透出自然光泽;而当夜幕降临,"夜间轻颜小紫瓶"则化身肌肤的修复师,在睡眠 中启动胶原蛋白再生程序,配合"发肤甲生物素微囊智珠"的靶向滋养,让晨起时的每一寸肌肤都透着被精 心照料过的生机。 可持续美学的多维诠释 在metoday的价值体系中,真正的美丽从不止于个体。品牌独创的"M瓶改造计划"将空瓶转化为花器、香 薰罐或桌面收纳,让每个使用周期都延续着环保理念。这种可持续思维同样渗透在产品研发中:玻璃瓶身 的避光设计既保护成分活性,又减少塑料污染。当消费者手持metoday产品时,握住的不仅是健康方案,更 是一份对地球的温柔承诺。 从纯净之地 ...